F. Connan

发表

Differential binding to frequent HLA-A alleles of p21 RAS derived peptides bearing oncogenic substitutions at position 12 or 13.

N. Balayn, J. Choppin, C. Demeur, 1997, Human immunology.

In situ detection of antigen-specific tumor-infiltrating lymphocytes using newly designed tetramers.

J. Guillet, M. Avril, M. Dalod, 2003, Journal of immunological methods.

Identification of p53 peptides recognized by CD8(+) T lymphocytes from patients with bladder cancer.

A. Hagnéré, J. Guillet, A. Vieillefond, 2001, Human immunology.

Among all human T-cell leukemia virus type 1 proteins, tax, polymerase, and envelope proteins are predicted as preferential targets for the HLA-A2-restricted cytotoxic T-cell response

J. Choppin, C. Pique, M. Dokhélar, 1996, Journal of virology.

response . for the HLA-A 2-restricted cytotoxic T-cell proteins are predicted as preferential targets proteins , tax , polymerase , and envelope Among all human T-cell leukemia virus type 1

J. Choppin, C. Pique, M. Dokhélar, 1996 .

Synthesis and antigenic properties of reduced peptide bond analogues of an immunodominant epitope of the melanoma MART‐1 protein

J. Briand, J. Guillet, A. Quesnel, 2001, Journal of peptide science : an official publication of the European Peptide Society.

Peptides derived from the whole sequence of BCR‐ABL bind to several class I molecules allowing specific induction of human cytotoxic T lymphocytes

J. Guillet, A. Buzyn, B. Varet, 1997, European journal of immunology.

The glycosidic antigen recognised by a novel monoclonal antibody, 75.12, is developmentally regulated on mouse embryonal carcinoma cells.

P. Avner, J. Le Pendu, D. Arnaud, 1983, The EMBO journal.

Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients.

C. Boitard, S. Muller, J. Briand, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Analysis of physical interactions between peptides and HLA molecules and application to the detection of human immunodeficiency virus 1 antigenic peptides

J. Levy, E. Bahraoui, E. Bahraoui, 1990, The Journal of experimental medicine.

Characteristics of HIV-1 Nef Regions

A. Bianco, J. Briand, J. Guillet, 2001 .

Differential presentation of endogenously processed cytotoxic T lymphocyte epitopes by mouse hepatocarcinoma cell lines induced by SV40 large T antigen.

J. Guillet, J. Choppin, M. Viguier, 1998, International immunology.

Antileukemic HLA-restricted T-cell clones generated with naturally processed peptides eluted from acute myeloblastic leukemia blasts.

D. Bonhomme, J. Guillet, D. Bouscary, 1998, Blood.

Partially modified retro-inverso pseudopeptides as non-natural ligands for the human class I histocompatibility molecule HLA-A2.

S. Muller, J. Briand, G. Guichard, 1996, Journal of medicinal chemistry.

A simple assay for detection of peptides promoting the assembly of HLA class I molecules

J. Hoebeke, J. Guillet, J. Choppin, 1994, European journal of immunology.

T cell response to Hu-D peptides in patients with anti-Hu syndrome

J. Delattre, J. Guillet, J. Dalmau, 2005, Journal of Neuro-Oncology.

Isolation and characterization of a monoclonal antibody specific for fibrinogen and fibrin of human origin.

P. Avner, B. Sola, F. Connan, 1983, Thrombosis research.

A partially modified retro-inverso pseudopeptide modulates the cytokine profile of CTL specific for an influenza virus epitope.

S. Muller, J. Briand, J. Hoebeke, 1998, Journal of immunology.

CTL Specific for an Influenza Virus Epitope Pseudopeptide Modulates the Cytokine Profile of A Partially Modified Retro-Inverso

S. Muller, J. Briand, J. Hoebeke, 1998 .

T cell‐mediated immunity to oncornavirus‐induced tumors IV. Preliminary evidence for a specific suppression of anti‐Moloney cell‐mediated immune response by autoimmune T cells

P. Debré, J. Leclerc, F. Connan, 1981, European journal of immunology.

Trypanosoma cruzi down-regulates lipopolysaccharide-induced MHC class I on human dendritic cells and impairs antigen presentation to specific CD8(+) T lymphocytes.

V. Verhasselt, M. Goldman, B. Vray, 2002, International immunology.

Melanoma peptide MART-1(27-35) analogues with enhanced binding capacity to the human class I histocompatibility molecule HLA-A2 by introduction of a beta-amino acid residue: implications for recognition by tumor-infiltrating lymphocytes.

J. Briand, J. Hoebeke, G. Guichard, 2000, Journal of medicinal chemistry.

Generation of Melan‐A/MART‐1‐specific CD8+ cytotoxic T lymphocytes from human naive precursors: Helper effect requirement for efficient primary cytotoxic T lymphocyte induction in vitro

J. Guillet, F. Le Gal, J. Choppin, 1997, International journal of cancer.

HLA‐dependent variations in human immunodeficiency virus Nef protein alter peptide/HLA binding

J. Guillet, J. Choppin, I. Couillin, 1995, European journal of immunology.

A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity.

J. Dausset, N. Rouas-Freiss, E. Carosella, 2001, Transplantation proceedings.

Definition of three species‐specific monoclonal antibodies recognizing antigenic structures present on human embryonal carcinoma cells which undergo modulation during in vitro differentiation

P. Avner, P. Andrews, D. Arnaud, 1984, International journal of cancer.

Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals

S. Hillion, D. Laplaud, J. Guillet, 2008, European journal of immunology.

Sensitivity to Proteasome Degradation Wealth of HLA-Binding Motifs and T Cell Epitopes : + Containing Multiple CD 8 Characteristics of HIV-1 Nef Regions

A. Bianco, J. Briand, J. Guillet, 2001 .

Influence of dominant HIV-1 epitopes on HLA-A3/peptide complex formation

Johan Hoebeke, J. Hoebeke, J. Guillet, 2006, Proceedings of the National Academy of Sciences.

Study of Antigen-Processing Steps Reveals Preferences Explaining Differential Biological Outcomes of Two HLA-A2-Restricted Immunodominant Epitopes from Human Immunodeficiency Virus Type 1

P. van Endert, A. Bianco, A. Bianco, 2002, Journal of Virology.

Endocytosis of an HIV‐derived lipopeptide into human dendritic cells followed by class I‐restricted CD8+ T lymphocyte activation

A. Dautry‐Varsat, J. Guillet, D. Hanau, 2000, European journal of immunology.

Automatic Sequence Design of Major Histocompatibility Complex Class I Binding Peptides Impairing CD8+ T Cell Recognition* 210

Alfonso Jaramillo, Shoshana J Wodak, S. Wodak, 2003, The Journal of Biological Chemistry.

Direct detection of peptide-dependent HLA variability by surface plasmon resonance.

J. Hoebeke, J. Guillet, J. Choppin, 1996, Molecular immunology.

Definition of the HLA-A29 peptide ligand motif allows prediction of potential T-cell epitopes from the retinal soluble antigen, a candidate autoantigen in birdshot retinopathy.

A. Toubert, D. Charron, I. Khalil, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Recognition of Human Proinsulin Leader Sequence by Class I–Restricted T-Cells in HLA-A*0201 Transgenic Mice and in Human Type 1 Diabetes

F. Lemonnier, C. Boitard, S. Muller, 2009, Diabetes.

Identification in humans of HPV‐16 E6 and E7 protein epitopes recognized by cytolytic T lymphocytes in association with HLA‐B18 and determination of the HLA‐B18‐specific binding motif

C. Bony, J. Levy, J. Guillet, 2000, European journal of immunology.

HLA-binding regions of HIV-1 proteins. I. Detection of seven HLA binding regions in the HIV-1 Nef protein.

J. Levy, J. Choppin, F. Martinon, 1991, Journal of immunology.

HLA-binding regions of HIV-1 proteins. II. A systematic study of viral proteins.

J. Levy, J. Choppin, F. Martinon, 1991, Journal of immunology.

Recognition of HLA class I molecules by antisera directed to synthetic peptides corresponding to different regions of the HLA-B7 heavy chain.

J. Levy, J. Briand, M. Bouillot, 1986, Journal of immunology.

Characteristics of HIV-1 Nef Regions Containing Multiple CD8+ T Cell Epitopes: Wealth of HLA-Binding Motifs and Sensitivity to Proteasome Degradation1

A. Bianco, J. Briand, J. Guillet, 2001, The Journal of Immunology.